Hi, I’ve noticed this too following a recent comparison across manufacturers.   Roche seem to be stand-alone by using this nomenclature, which they have determined using a different procedure (n=21, within run imprecision) to that which they use to define LOD (n=60 of the blank + 2SDs of low conc. sample, CLSI approach essentially). I don’t find this additional parameter useful, least to say I wouldn’t be happy reporting to a concn. <LOD (or <LLOQ)! 

 

…Changing tac briefly from PSA to high sensitivity cTn and use of the LOD for ACS r/o. This perhaps represents somewhat of a paradigm shift as regards testing and reporting in general terms however is it more acceptable/palatable to report to the LOD for hs-cTn because it’s in the guidelines and perhaps a larger body of (robust) evidence supporting its use compared to that available re. use of PSA’s LOD for monitoring biochem. recurrence?...same/similar issues of quality control/assurance though to contend  with in both circumstances? (Australian report noted earlier from mailbase..chilling!). 

 

KR, Graham

 

Dr Graham Lee PhD FRCPath

Consultant Clinical Biochemist/UCD Assistant Clinical Professor

Department of Clinical Biochemistry & Diagnostic Endocrinology

Mater Misericordiae University Hospital and

Cappagh National Orthopaedic Hospital, Dublin

Midland Regional Hospital, Mullingar, University College Dublin

Address: MMUH, Eccles St, Dublin 7

Tel:00353 1 8034983

 

 

From: Clinical biochemistry discussion list [mailto:[log in to unmask]] On Behalf Of Mustafa Serteser
Sent: 03 July 2018 10:37
To: [log in to unmask]
Subject: Re: Reporting of low level Total PSA results

 

Dear Colleagues,

 

 

Is it possible for lower detection limit to be less than LoB?

 

According to EP17A; “lower limit of detection” also stands for LoD. It will also be the case that, LoB<LoD£LoQ.

 

I think, first this discrepancies on Roche PSA assay characterisics must be solved/corrected.

 

Regards.

MS_GMY

 

From: Clinical biochemistry discussion list [mailto:[log in to unmask]] On Behalf Of Lynch Mark - Consultant
Sent: Monday, July 2, 2018 2:04 PM
To: [log in to unmask]
Subject: Reporting of low level Total PSA results

 

This e-mail is covered by the disclaimer found at the end of the message.
 
 

Dear Colleagues

Our lab uses the Roche Total PSA assay (04491734190) and the kit insert states the following with respect to Limits and ranges [CLSI EP17-A]:

Measuring range 0.003 – 100 ng/mL

Lower detection Limit 0.003 ng/mL

Limit of Blank 0.006 ng/mL

Limit of Detection 0.014 ng/mL

 

At present we report our Total PSAs to one decimal place and report any results less than 0.1 as <0.1 ug/L.

[Our lowest IQC (BioRad Lyphochek) has a target value of 0.1 and runs with a CV of just under 6%]

 

We are getting an increasing number of requests to report down to much lower values.

 

I was wondering what other Roche users report down to? And indeed what users of other assays do?

 

Regards

Mark Lynch

Altnagelvin Hospital

 
This email is confidential and intended solely for the use of the individual to whom it is addressed. Any views or opinions presented are solely those of the author and do not necessarily represent the views of the Trust or organisation it was sent from.
If you are not the intended recipient, be advised that you have received this email in error and that any use, dissemination, forwarding, printing, or copying of this email is strictly prohibited. 
If you have received this email in error please contact the sender.
The content of this e-mail and any attachments or replies may be subject to public disclosure under the Freedom of Information Act 2000, unless legally exempt.

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

This e-mail and any files transmitted with it contain information which may be confidential and which may also be privileged and is intended solely for the use of the individual or entity to which it is addressed. Unless you are the intended recipient you may not copy or use it, or disclose it to anyone else. Any opinions expressed are that of the individual and not necessarily that of Mater Misericordiae University Hospital. ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/